511 related articles for article (PubMed ID: 26778524)
1. Comparison of Intensive Versus Moderate Lipid-Lowering Therapy on Fibrous Cap and Atheroma Volume of Coronary Lipid-Rich Plaque Using Serial Optical Coherence Tomography and Intravascular Ultrasound Imaging.
Hou J; Xing L; Jia H; Vergallo R; Soeda T; Minami Y; Hu S; Yang S; Zhang S; Lee H; Yu B; Jang IK
Am J Cardiol; 2016 Mar; 117(5):800-6. PubMed ID: 26778524
[TBL] [Abstract][Full Text] [Related]
2. Serial Optical Coherence Tomography and Intravascular Ultrasound Analysis of Gender Difference in Changes of Plaque Phenotype in Response to Lipid-Lowering Therapy.
Minami Y; Hou J; Xing L; Jia H; Hu S; Vergallo R; Soeda T; Lee H; Zhang S; Yu B; Jang IK
Am J Cardiol; 2016 Jun; 117(12):1890-5. PubMed ID: 27138187
[TBL] [Abstract][Full Text] [Related]
3. Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study.
Dai J; Hou J; Xing L; Jia H; Hu S; Soeda T; Minami Y; Ong D; Vergallo R; Zhang S; Lee H; Yu B; Jang IK
Coron Artery Dis; 2017 May; 28(3):209-217. PubMed ID: 28059849
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Rosuvastatin Versus Atorvastatin for Coronary Plaque Stabilization.
Thondapu V; Kurihara O; Yonetsu T; Russo M; Kim HO; Lee H; Soeda T; Minami Y; Jang IK
Am J Cardiol; 2019 May; 123(10):1565-1571. PubMed ID: 30851941
[TBL] [Abstract][Full Text] [Related]
5. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.
Takarada S; Imanishi T; Ishibashi K; Tanimoto T; Komukai K; Ino Y; Kitabata H; Kubo T; Tanaka A; Kimura K; Mizukoshi M; Akasaka T
JACC Cardiovasc Interv; 2010 Jul; 3(7):766-72. PubMed ID: 20650439
[TBL] [Abstract][Full Text] [Related]
6. Pathologic Intimal Thickening Plaque Phenotype: Not as Innocent as Previously Thought. A Serial 3D Intravascular Ultrasound Virtual Histology Study.
Kovarnik T; Chen Z; Wahle A; Zhang L; Skalicka H; Kral A; Lopez JJ; Horak J; Sonka M; Linhart A
Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):25-33. PubMed ID: 27615562
[TBL] [Abstract][Full Text] [Related]
7. Is the effect of atorvastatin 60 mg on stabilization of lipid-rich plaque equivalent to that of rosuvastatin 10 mg? A serial optical coherence tomography combined with intravascular ultrasound imaging.
Xu M; Demuyakor A; Hu S; Liu H; Zhao C; Chen T; Qin Y; Xu Y; Feng X; Zeng M; Weng Z; Gao Z; Hou J; Jia H; Zhang S; Yu B
Catheter Cardiovasc Interv; 2021 May; 97 Suppl 2():1097-1107. PubMed ID: 33864710
[TBL] [Abstract][Full Text] [Related]
8. Intraplaque neovascularization attenuated statin benefit on atherosclerotic plaque in CAD patients: A follow-up study with combined imaging modalities.
Liu X; Sun C; Gu X; Liu X; Wang X; Wang X; Xie Z; Tian J; Yu B
Atherosclerosis; 2019 Aug; 287():134-139. PubMed ID: 31272069
[TBL] [Abstract][Full Text] [Related]
9. Comparison of optical coherence tomography and intravascular ultrasound for evaluation of coronary lipid-rich atherosclerotic plaque progression and regression.
Xie Z; Tian J; Ma L; Du H; Dong N; Hou J; He J; Dai J; Liu X; Pan H; Liu Y; Yu B
Eur Heart J Cardiovasc Imaging; 2015 Dec; 16(12):1374-80. PubMed ID: 25911116
[TBL] [Abstract][Full Text] [Related]
10. Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study.
Räber L; Koskinas KC; Yamaji K; Taniwaki M; Roffi M; Holmvang L; Garcia Garcia HM; Zanchin T; Maldonado R; Moschovitis A; Pedrazzini G; Zaugg S; Dijkstra J; Matter CM; Serruys PW; Lüscher TF; Kelbaek H; Karagiannis A; Radu MD; Windecker S
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1518-1528. PubMed ID: 30553686
[TBL] [Abstract][Full Text] [Related]
11. Association of cardiorespiratory fitness with characteristics of coronary plaque: assessment using integrated backscatter intravascular ultrasound and optical coherence tomography.
Yoshikawa D; Ishii H; Kurebayashi N; Sato B; Hayakawa S; Ando H; Hayashi M; Isobe S; Okumura T; Hirashiki A; Takeshita K; Amano T; Uetani T; Yamada S; Murohara T
Int J Cardiol; 2013 Jan; 162(2):123-8. PubMed ID: 21636151
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional morphological response of lipid-rich coronary plaques to statin therapy: a serial optical coherence tomography study.
Wang Z; Cho YS; Soeda T; Minami Y; Xing L; Jia H; Aguirre A; Vergallo R; Lee H; Fujimoto JG; Yu B; Jang IK
Coron Artery Dis; 2016 Aug; 27(5):350-6. PubMed ID: 27105047
[TBL] [Abstract][Full Text] [Related]
14. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?
Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK
Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018
[TBL] [Abstract][Full Text] [Related]
15. Does spotty calcification attenuate the response of nonculprit plaque to statin therapy?: A serial optical coherence tomography study.
Afolabi A; Mustafina I; Zhao L; Li L; Sun R; Hu S; Zhang S; Jia H; Guilio G; Yu B
Catheter Cardiovasc Interv; 2018 Feb; 91(S1):582-590. PubMed ID: 29359491
[TBL] [Abstract][Full Text] [Related]
16. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS.
Hattori K; Ozaki Y; Ismail TF; Okumura M; Naruse H; Kan S; Ishikawa M; Kawai T; Ohta M; Kawai H; Hashimoto T; Takagi Y; Ishii J; Serruys PW; Narula J
JACC Cardiovasc Imaging; 2012 Feb; 5(2):169-77. PubMed ID: 22340823
[TBL] [Abstract][Full Text] [Related]
17. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.
Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
[TBL] [Abstract][Full Text] [Related]
19. Impact on optical coherence tomographic coronary findings of fluvastatin alone versus fluvastatin + ezetimibe.
Habara M; Nasu K; Terashima M; Ko E; Yokota D; Ito T; Kurita T; Teramoto T; Kimura M; Kinoshita Y; Tsuchikane E; Asakura Y; Matsubara T; Suzuki T
Am J Cardiol; 2014 Feb; 113(4):580-7. PubMed ID: 24388622
[TBL] [Abstract][Full Text] [Related]
20. Effect of Statin Therapy on Fibrous Cap Thickness in Coronary Plaques Using Optical Coherence Tomography: A Systematic Review and Meta-Analysis.
Zheng G; Chen J; Lin C; Huang X; Lin J
J Interv Cardiol; 2015 Dec; 28(6):514-22. PubMed ID: 26487187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
